Use access key #2 to skip to page content.
$17.14 0.27 (1.60%)
10/10/2008 4:00 PM

Regeneron Pharmaceuticals, Inc. (REGN)

CAPS Rating:
*

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.

View All Commentary (REGN)

Recs

0

Avatar jsIRA (< 20) Submitted: 6/03/08 5:35 PM : Outperform Start Price: $18.64 REGN Score: 10.67

Good bio tech company. Will see year high soon

Report this Post Replies: 0 | Reply

Featured Broker Partners